An experimental HIV vaccine that's worked better than anything else tried so far is going to be tested in South Africa, U.S. health officials said Wednesday.
National Institute for Health and Clinical Excellence (NICE) in the UK has issued a Final Appraisal Determination (FAD) recommending the use of 'Victrelis'® (boceprevir) in combination with peginterferon alfa and ribavirin ('dual therapy') as an option for the treatment of genotype 1 chronic hepatitis C
Newly updated US antiretroviral treatment guidelines are recommending antiretroviral treatment for all people with HIV infection, with particular emphasis on treatment for: people with CD4 cell counts below 500
Bristol-Myers Squibb Company (NYSE: BMY) has announced the full results, published in the New England Journal of Medicine, from a Phase II clinical trial in patients with hepatitis C virus (HCV) genotype 1 who had not responded to prior therapy with PEG-interferon alfa and ribavirin (‘null responders’*).
© Copyright 2011 Positive Nation, Talent Media.
Designd & powerd by ENTWURF.